161 related articles for article (PubMed ID: 36046377)
21. Integrated analysis of expression, prognostic value and immune infiltration of GSDMs in hepatocellular carcinoma.
Hu K; Xu Z; Yao L; Yan Y; Zhou L; Li J
Aging (Albany NY); 2021 Nov; 13(21):24117-24135. PubMed ID: 34731088
[TBL] [Abstract][Full Text] [Related]
22. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
23. Identification of the prognostic, diagnostic, and biological significance of the miR-148a-3p/cathepsin A axis in hepatocellular carcinoma.
Zhao X; Chai W; Wang T; Chen X; Zhang L; Li F; Liu R
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23208. PubMed ID: 36065643
[TBL] [Abstract][Full Text] [Related]
24. Early growth response 2 and Egr3 are unique regulators in immune system.
Taefehshokr S; Key YA; Khakpour M; Dadebighlu P; Oveisi A
Cent Eur J Immunol; 2017; 42(2):205-209. PubMed ID: 28860938
[TBL] [Abstract][Full Text] [Related]
25. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
Front Genet; 2022; 13():965805. PubMed ID: 36159990
[TBL] [Abstract][Full Text] [Related]
26. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors.
Patwardhan S; Gashler A; Siegel MG; Chang LC; Joseph LJ; Shows TB; Le Beau MM; Sukhatme VP
Oncogene; 1991 Jun; 6(6):917-28. PubMed ID: 1906159
[TBL] [Abstract][Full Text] [Related]
27. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand.
Zhang S; Xia C; Xu C; Liu J; Zhu H; Yang Y; Xu F; Zhao J; Chang Y; Zhao Q
Int J Oncol; 2017 Mar; 50(3):805-814. PubMed ID: 28098878
[TBL] [Abstract][Full Text] [Related]
28. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.
Wang ZD; Qu FY; Chen YY; Ran ZS; Liu HY; Zhang HD
J Zhejiang Univ Sci B; 2017 Jan.; 18(1):27-36. PubMed ID: 28070994
[TBL] [Abstract][Full Text] [Related]
29. EGR3 as a potential susceptibility gene for schizophrenia in Korea.
Kim SH; Song JY; Joo EJ; Lee KY; Ahn YM; Kim YS
Am J Med Genet B Neuropsychiatr Genet; 2010 Oct; 153B(7):1355-60. PubMed ID: 20687139
[TBL] [Abstract][Full Text] [Related]
30. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells.
Peng WX; Xiong EM; Ge L; Wan YY; Zhang CL; Du FY; Xu M; Bhat RA; Jin J; Gong AH
Exp Cell Res; 2016 Jan; 340(1):62-70. PubMed ID: 26708617
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
[TBL] [Abstract][Full Text] [Related]
32. Distinct functions of egr gene family members in cognitive processes.
Poirier R; Cheval H; Mailhes C; Garel S; Charnay P; Davis S; Laroche S
Front Neurosci; 2008 Jul; 2(1):47-55. PubMed ID: 18982106
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
Ma X; Ding Y; Zeng L
BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
[TBL] [Abstract][Full Text] [Related]
35. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Kerr J
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114612
[TBL] [Abstract][Full Text] [Related]
36. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract][Full Text] [Related]
37. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
Front Immunol; 2022; 13():892750. PubMed ID: 35812416
[TBL] [Abstract][Full Text] [Related]
38. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma.
Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX
Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931
[TBL] [Abstract][Full Text] [Related]
40. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
